Use of hormone replacement therapy before and after ovarian cancer diagnosis, and ovarian cancer survival
10.1002/ijc.22218
Saved in:
Main Authors: | Mascarenhas, C., Lambe, M., Bellocco, R., Bergfeldt, K., Riman, T., Persson, I., Weiderpass, E. |
---|---|
Other Authors: | CENTER FOR MOLECULAR EPIDEMIOLOGY |
Format: | Article |
Published: |
2015
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/120822 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Haemostatic status in patients with ovarian cancer compared with patients with benign ovarian cysts and the study of the relationships between haemostatic levels in ovarian cancer patients with known survival outcome
by: KOH CHEE LIANG, STEPHEN
Published: (2010) -
Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
by: Lu, Yen-Shen, et al.
Published: (2022) -
Ovarian Cancer
Published: (2017) -
The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence
by: Verkooijen, H.M., et al.
Published: (2011) -
Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study
by: Orgeas, C.C., et al.
Published: (2011)